Pharmaceutical Grade Lithium Carbonate Market Size, Manufacturers, and Competitive Landscape

The report "Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028", is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028.

As the understanding of mental health conditions like bipolar disorder improves and more accurate diagnostic tools become available, there is expected to be an increased demand for medicines having pharmaceutical grade lithium carbonate that are used to manage these conditions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146574055

Browse in-depth TOC on "Pharmaceutical Grade Lithium Carbonate Market"

170 – Tables

42 – Figures

150 – Pages

By application, extended-release segment is estimated to account for the largest market share in 2023.

Certain mental health disorders can experience fluctuations in symptoms when the drug concentration in the body varies. Extended release medications help to smooth out these fluctuations and provide a more constant effect. Also, extended release formulations can be preferred by healthcare providers because they offer a more controlled and predictable drug release profile, making it easier to tailor treatment plans to individual patient needs. All these factors are expected to enhance the demand for extended release pharmaceutical grade lithium carbonate medicines during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=146574055 

North America was the largest region in the pharmaceutical grade lithium carbonate market in 2022, by value.

The development of technology and innovation across several industries are characteristics of North America. Manufacturers of pharmaceutical grade lithium carbonates in the region make huge investment in the research & development to improve the performance qualities of medicines. The pharmaceutical grade lithium carbonate market in North America is expanding as a result of technological developments in pharmaceutical sector and awareness regarding mental health among people. Awareness campaigns and patient advocacy groups focusing on mental health conditions is contributing to enhance the understanding and acceptance of treatment options related to mental illness. This is expected to drive the market for pharmaceutical grade lithium carbonate in the country.

Pharmaceutical Grade Lithium Carbonate Companies

The major players operating in the pharmaceutical grade lithium carbonate market include Livent Corporation (US), Albemarle Corporation (US), Jiangsu Lianhuan Pharmaceutical Co., Ltd. (China), American Elements (US), Globe Química (US), Jiangsu Nhwa Pharmaceutical Co., Ltd. (China), Panchsheel Organics Ltd (POLTD) (India), Blanver (Brazil), and others.

Livent Corporation

Livent Corporation is engaged in manufacturing good performance product solutions such as energy storage & battery systems, polymers, grease, aerospace, and pharmaceuticals & agrochemicals. Livent operates manufacturing sites in the US, England, India, China, and Argentina. The company is one of the manufacturers of lithium compounds with various performance levels. Its good performance lithium compounds play a crucial role in the manufacture of medicines and polymers as well as existing and future high energy density batteries used in electric car applications. The company has a strong focus in the majority of the global markets for lithium compounds, with significant expansion taking place in Asia, followed by Europe and the US.

Speak to Expert: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=146574055

Albemarle Corporation

Albemarle Corporation caters to various end markets such as energy storage, petroleum refining, consumer electronics, building, automotive, lubricants, pharmaceuticals, and crop protection. The company aims at maintaining leading positions in the areas of specialty chemicals industry through commercial and geographic diversity, technical know-how, access to resources, global manufacturing base, and strategic focus on core base technologies. Albemarle operates around 25 production and research & development (R&D) facilities. Albemarle Corporation has acquired companies and formed joint ventures as a part of its corporate growth strategy, and it plans to look for acquisition and joint venture opportunities in the future.

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is engaged in integrating R&D, manufacturing, and sales in the pharmaceutical sector. It offers various products such as urinary system (Eprelide, terazosin), antihistamines (Ebastine Tablets, Terfenadine Tablets), cardiovascular drugs (Felodipine tablets, simvastatin tablets), steroid hormones (levonorgestrel, danazol capsules) and antibiotics (azithromycin tablets, doxycycline hydrochloride tablets). It is one of the major 100 businesses in China's pharmaceutical sector and has seen a number of advancements. The company has a strong focus on research & development with the formation of two R&D facilities in China.

Important Facts about This Market Report:

• This research report reveals this business overview, product overview, market share, demand and supply ratio, supply chain analysis, and import/export details.
• The Industry report captivates different approaches and procedures endorsed by the market key players to make crucial business decisions.
• This research presents some parameters such as production value, marketing strategy analysis, Distributors/Traders, and effect factors are also mentioned.
• The historical and current data is provided in the report based on which the future projections are made and the industry analysis is performed.
• The import and export details along with the consumption value and production capability of every region are mentioned in the report.
• Porter's five forces analysis, value chain analysis, and SWOT analysis are some additional important parameters used for the analysis of market growth.
• The report provides the clients with facts and figures about the market on the basis of the evaluation of the industry through primary and secondary research methodologies.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=146574055

Frequently Asked Questions (FAQ):

What is the current size of the pharmaceutical grade lithium carbonate market?

Which region is expected to hold the largest market share in the pharmaceutical grade lithium carbonate market?

Which is the major application of pharmaceutical grade lithium carbonate?

Who are the major players operating in the pharmaceutical grade lithium carbonate market?

What is the total CAGR expected to record for the pharmaceutical grade lithium carbonate market during 2023-2028?

The market is expected to record a CAGR of 3.3% from 2023-2028.